MarketCatalyst
← Back to Research
Earnings

Synaptics Fiscal Q1 2027 EPS Tops Estimates at $1.26, but Revenue Misses at $294.0M

Revenue of $294.0M vs. $315.6M expected and adjusted EPS of $1.26 vs. $1.25; revenue up 0.5% from a year earlier.

Published Nov 5, 2026 · 4:07 PM ET · 2 min read

Synaptics (SYNA) posted mixed fiscal first-quarter 2027 results, with adjusted EPS above the estimate and revenue below it. Revenue was $294.0 million, up 0.5% from a year earlier, below the $315.6 million estimate, and adjusted EPS was $1.26, up 16% from a year earlier, above the $1.25 estimate.

Shares were unchanged in after-hours trading as of 4:04 p.m. ET, to $116.40 from a $116.40 close.

$1.26
Adjusted EPS, up 16% YoY vs. $1.25 estimate
$294.0M
Revenue, up 0.5% YoY vs. $315.6M estimate
0.0%
Shares after hours as of 4:04 p.m. ET

Fiscal Q1 2027 scorecard

ParametersExpectedActualBeat/Miss
Adjusted EPS$1.25$1.26Beat by 0.8%
Revenue$315.6M$294.0MMiss by 6.8%
ChangeYoYQoQ
Adjusted EPS▲ 16%▲ 2.4%
Revenue▲ 0.5%▼ 4.5%

By our calculation, revenue was $21.6 million below the estimate and adjusted EPS was $0.01 above it. The QoQ column compares with the previous quarter's revenue of $308.0 million and adjusted EPS of $1.23. The YoY column compares with $292.5 million and $1.09 in the same quarter a year earlier.

Track record

  • EPS record. Adjusted EPS beat the estimate in 8 of the last 8 reports, including this one.
  • Revenue record. Revenue beat the estimate in 4 of the last 8 reports.
  • Revenue trend. Revenue over the last 5 reports, oldest first: $292.5 million, $302.5 million, $294.2 million, $308.0 million and $294.0 million.

What to watch

  • Next-quarter estimates. Consensus calls for EPS of $1.36 and revenue of $328.2 million next quarter, based on 7 analysts.
  • Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 0.5% increase to $294.0 million.
  • Estimate record. Whether Synaptics extends a record of beating EPS estimates in 8 of its last 8 reports.
  • Related coverage. See our reports on iRhythm, Eton Pharmaceuticals, BlackLine and BJ's Restaurants.

Sources: Results are from Synaptics's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Synaptics's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.

Readers also read

MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.

Synaptics Fiscal Q1 2027 EPS Tops Estimates at $1.26